Renal Effects of Empagliflozin in Patients with Type 2 Diabetes Mellitus
(2022)
Journal Article
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2022). Renal Effects of Empagliflozin in Patients with Type 2 Diabetes Mellitus. Current medicinal chemistry, 30(25), 2850-2863. https://doi.org/10.2174/0929867329666220831151645
Type 2 diabetes mellitus (T2DM) is one of the main causes of mortality and morbidity worldwide. It leads to various long-term complications such as diabetic nephropathy. Diabetes nephropathy is the leading cause of renal failure in patients with chro... Read More about Renal Effects of Empagliflozin in Patients with Type 2 Diabetes Mellitus.